|
HS Code |
939899 |
| Chemical Formula | C6H8N2O2S |
| Molecular Weight | 172.205 g/mol |
| Appearance | White to off - white solid |
| Melting Point | Typically in a certain range (exact value may vary by source) |
| Solubility In Water | Poorly soluble |
| Solubility In Organic Solvents | Soluble in some organic solvents like ethanol, chloroform |
| Pka | Related to its acidic and basic nature, specific value exists |
| Density | Specific density value (needs to be determined experimentally) |
| Stability | Stable under normal conditions, but may react with strong oxidizing agents |
As an accredited 2-Aminothiazole-4-Carboxylic Acid Ethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2 - Aminothiazole - 4 - Carboxylic Acid Ethyl Ester in sealed chemical - grade packaging. |
| Shipping | 2 - Aminothiazole - 4 - Carboxylic Acid Ethyl Ester is shipped in well - sealed, corrosion - resistant containers. It's transported under controlled conditions to prevent degradation, with proper labeling indicating its chemical nature for safety. |
| Storage | 2 - Aminothiazole - 4 - Carboxylic Acid Ethyl Ester should be stored in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and exposure to air, which could lead to degradation. Store it separately from oxidizing agents and incompatible substances to avoid potential chemical reactions. |
|
In the synthesis of ceftazidime, cefodizime, and third-generation cephalosporin side-chain acids, 2-aminothiazole-4-carboxylic acid ethyl ester functions as the pivotal heterocyclic precursor. The manufacturing sequence converts the ester into 2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid ethyl ester (ATMAE) through a two-stage oximation-O-methylation protocol. Hydrolysis of the ethyl ester subsequently liberates the free carboxylic acid, which is activated as an acid chloride or mixed anhydride for acylation of the 7-aminocephalosporanic acid nucleus. Strict temperature control during oximation must be maintained at 0–5°C; excursions above 8°C promote formation of the E-isomer oxime byproduct, which is pharmacopoeially controlled to below 0.3% by HPLC. The oximation charge ratio requires 1.05 equivalents of sodium nitrite relative to the active methylene group, with hydrochloric acid added to maintain pH 1.8–2.2 and prevent accelerated nitrosamine generation. Methylation with dimethyl sulfate or methyl iodide under phase-transfer conditions (tetrabutylammonium bromide at 3.0 mol%) proceeds at 25–30°C, and residual methylating agent is quenched with aqueous ammonia to pH 8.5. Residual solvent compliance follows ICH Q3C guidelines, with methyl iodide limited to 2 ppm, methanol to 3000 ppm, and toluene to 890 ppm. The final side-chain acid is typically crystallized from isopropanol-water to achieve an assay above 99.0% and a heavy metals limit below 10 ppm as per Ph. Eur. monograph 01/2023:1407. On commercial-scale campaigns, stainless steel (SS316L) reactors are standard, but chloride stress-corrosion cracking has been observed when reaction mass is held at pH below 0.5 during oximation; operations with Hastelloy C-22 inserts are recommended for campaigns exceeding 10 metric tons. Centrifugal wiped-film evaporators operated at 45°C jacket temperature and 15 mbar vacuum are employed for ester solvent displacement without thermal degradation of the oxime ether.
Direct coupling of the acid chloride derived from the hydrolyzed ester to 7-amino-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid delivers cefodizime; reaction is conducted in dichloromethane at −10°C with triethylamine as acid scavenger, requiring a water content below 0.05% Karl Fischer to avoid bis-amide formation. Crystallization from acetone-water yields the monosodium salt meeting USP 〈621〉 chromatographic purity of not less than 98.0% for the main peak. Which reductive chlorination pathway converts 2-aminothiazole-4-carboxylate to 2-chloro-5-chloromethylthiazole at multi-ton scale?The synthesis of 2-chloro-5-chloromethylthiazole (CCMT), the indispensable chloroheterocycle for neonicotinoid insecticides such as thiamethoxam and clothianidin, depends on sequential ester-to-alcohol reduction, hydroxy-to-chloride displacement, and Sandmeyer-type amino-to-chloro exchange on the thiazole ring. 2-Aminothiazole-4-carboxylic acid ethyl ester is first reduced to 2-amino-4-hydroxymethylthiazole. Sodium borohydride with calcium chloride in tetrahydrofuran at 65°C provides the alcohol in 85–89% isolated yield when molar ratios are held at 1:2.5:2.0 (ester:NaBH₄:CaCl₂); lithium aluminium hydride at −5°C to 0°C in diethyl ether achieves 93% conversion but requires ultra-dry solvents and generates pyrophoric aluminium sludges that impose electrostatic grounding on all transfer piping. The subsequent chlorination with thionyl chloride in toluene at 75–80°C for 5 h converts the hydroxymethyl group to chloromethyl; residual SO₂ and HCl are stripped with nitrogen at 60°C to below 50 ppm prior to the next stage. The amino group on the thiazole ring is diazotized with sodium nitrite in concentrated hydrochloric acid at −8°C to −3°C, and the resulting diazonium solution is introduced into a copper(I) chloride catalyst loop at 0–2°C. Critical failure modes include runaway exothermic decomposition when diazonium intermediate is held above 5°C for more than 90 seconds, a hazard mitigated by continuous flow processing with residence time limited to <30 s and back-pressure regulated at 2.5 bar. The crude CCMT is vacuum-distilled (boiling point 104–106°C at 15 mmHg) and stored under nitrogen with 0.1% butylated hydroxytoluene inhibitor to suppress polymerization. Technical-grade CCMT must meet FAO Specification 689/TC: assay ≥ 97.0%, sulfated ash ≤ 0.1%, and water ≤ 0.2%. The ethyl ester route is preferred over the 2-aminothiazole-4-carboxylic acid route owing to lower water solubility and easier extractive isolation during the reduction step; eight consecutive campaign runs at a facility in Jiangsu demonstrated 2.1% batch-to-batch assay variability, with the largest deviation attributable to residual iron from reactor walls accelerating diazonium decomposition. Final products thiamethoxam and clothianidin are formulated as suspension concentrates or water-dispersible granules, and the CCMT intermediate's residual 2-aminothiazole-4-carboxylic acid level must be held below 0.15% to avoid unregistered impurities in the crop protection regulatory dossier.
Thiazole orange chromophore generation and spectral tuning in nucleic acid gel stainsCondensation of 2-aminothiazole-4-carboxylic acid ethyl ester with excess 1-alkyl-4-methylquinolinium salts affords the asymmetric cyanine dye thiazole orange (TO), which exhibits a π→π* absorption maximum at 501 nm (ε ≈ 63 000 M⁻¹ cm⁻¹ in methanol) and fluorescence quantum yield exceeding 0.4 only upon intercalation into double-stranded DNA. The reaction is performed in anhydrous DMF containing 1.2 equivalents of N-methyl-4-methylquinolinium iodide and 1.8 equivalents of triethylamine, heated to 80°C for 8–10 h under 99.999% nitrogen. Unreacted ester is removed by trituration with ethyl acetate, and the crude methine-bridged product is purified by reverse-phase chromatography (C18, acetonitrile/0.1% TFA gradient). The carboxyethyl group can be retained or hydrolyzed to the free carboxylic acid to enable active ester conjugation to oligonucleotide probes via NHS/DCC coupling at 4°C in pH 7.4 HEPES buffer. Batch-to-batch photometric performance is governed by the content of the over-alkylated bis-intercalator impurity formed at >1.5 equivalents of quinolinium salt; this impurity quenches fluorescence through exciton coupling and must be capped below 0.6 area-% by HPLC (detection at 280 nm). The terminal dye is routinely QC‑released against the Colour Index CI 51880 standard, with additional ISO 13485:2016 compliant documentation for IVD manufacturers. Portable forensic quantitation kits formulate TO as 1 µM staining solution in Tris-EDTA buffer with 0.5% DMSO, having been validated on agarose gels per ASTM E2098-00 (determination of DNA fragment sizes) and exhibiting detection limits down to 15 pg/band under 300 nm transillumination. Hydrolysis of the ethyl ester moiety under alkaline conditions yields 2-aminothiazole-4-carboxylic acid (HATCA), a planar N,O-chelating ligand that forms paddlewheel-type secondary building units with Cu(II) or Zn(II) nodes in metal–organic frameworks. A typical solvothermal synthesis combines HATCA with Cu(NO₃)₂·2.5H₂O in a 2:1 ligand-to-metal molar ratio in DMF/EtOH/H₂O (3:1:1 v/v) at 85°C for 48 h in a PTFE-lined Parr autoclave, yielding blue octahedral crystals of [Cu₂(HATCA)₄]·2DMF. Activation by solvent exchange with methanol and evacuation at 120°C for 12 h under dynamic vacuum (10⁻³ mbar) generates a BET surface area of 620–680 m² g⁻¹ (N₂ at 77 K, ASTM D6556-21) and a pore volume of 0.32 cm³ g⁻¹. The amino group remains uncoordinated and provides a post-synthetic modification site for grafting acyl chlorides or isocyanates, enabling pore-environment tuning for selective CO₂/CH₄ separation at 298 K and 1 bar. The framework maintains structural integrity up to 310°C by thermogravimetric analysis under N₂, beyond which decarboxylation liberates CO₂ and collapses the lattice. Performance in cyclic water adsorption-desorption (RH 5–95%) shows 8% mass loss after 50 cycles, attributable to slow ligand hydrolysis at copper centres when steam exposure exceeds 48 h consecutively. For comparison with the ester-protected precursor, direct use of 2-aminothiazole-4-carboxylic acid ethyl ester in one-pot solvothermal conditions leads to in-situ ester hydrolysis and identical topology, though crystal nucleation is retarded by 6–10 h due to slow base generation from DMF decomposition; this lag is eliminated by pre-hydrolysing the ester with 2 M NaOH in methanol and isolating HATCA as the sodium salt prior to framework assembly. The ethyl ester feedstock is thus advantageous only when integrated with continuous-flow alkaline hydrolysis modules that feed directly into crystallization reactors, avoiding isolation losses of the zwitterionic free acid. If bromoacetyl bromide is used to N-acylate, subsequent Suzuki coupling broadens kinase-inhibitor fragment libraries2-Aminothiazole-4-carboxylic acid ethyl ester undergoes chemo-selective acylation at the exocyclic amino group when treated with bromoacetyl bromide in dichloromethane at 0°C in the presence of 2.0 equivalents of triethylamine as HCl scavenger. The resulting 2-(2-bromoacetamido)thiazole-4-carboxylic acid ethyl ester is isolated as a stable off-white solid (mp 142–144°C) and is deployed as a bifunctionalised fragment in diversity-oriented discovery of cyclin-dependent kinase (CDK) and glycogen synthase kinase-3β (GSK-3β) inhibitors. The α-bromoamide participates in palladium-catalyzed Suzuki−Miyaura cross-couplings with arylboronic acids bearing electron-withdrawing substituents: typical conditions employ Pd(PPh₃)₄ (1.5 mol%), K₂CO₃ (3 equiv), and toluene/EtOH/H₂O (5:2:1) at 80°C for 12 h, delivering derivatives with 70–85% isolated yields. The ethyl ester handle is subsequently hydrolysed with LiOH in THF/H₂O to the free carboxylic acid, enabling HATU-mediated amide bond formation with a variety of substituted anilines or heterocyclic amines. Critical quality attributes for the building block supplied to medicinal chemistry groups include purity ≥ 98.5% (HPLC, 254 nm), residual palladium ≤ 5 ppm (ICP-MS, Ph. Eur. 2.4.20), and absence of dimeric thiazole-thiazole homocoupling products that co-elute with the desired biaryl-pharmacophore at RRT 1.13. Production-scale preparation of the bromoacetyl intermediate is executed under cGMP for early-phase clinical supply; charge of bromoacetyl bromide must be controlled to a ±0.3% weight accuracy because excess reagent attacks the thiazole C-5 position at temperatures above 10°C, forming a genotoxic impurity that is purgeable only by preparative SFC. The downstream terminal APIs, produced after coupling and further cyclisation, are formulated as film-coated tablets with dissolution tested per USP 〈711〉 Apparatus II at 50 rpm in pH 6.8 phosphate buffer. |
Competitive 2-Aminothiazole-4-Carboxylic Acid Ethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Method | Specification Limit | Mean ± 1σ Observed |
|---|---|---|---|
| Assay (anhydrous, solvent-free) | HPLC, external standard, USP 〈621〉 | ≥ 99.0% | 99.37 ± 0.18% |
| Melting range | DSC, 10 K/min, nitrogen purge | 168–172°C | onset 169.1°C, peak 170.4 ± 0.9°C |
| Water content | Karl Fischer coulometry, ISO 760 | ≤ 0.5% | 0.11 ± 0.06% |
| Sulphated ash | Ph. Eur. 2.4.14, 600°C | ≤ 0.1% | 0.02 ± 0.01% |
| Residual 2-aminothiazole-4-carboxylic acid | HPLC, ion-pair, 210 nm | ≤ 0.5% | 0.08 ± 0.05% |
| Ethyl acetate | HS-GC-MS, SIM mode | ≤ 100 ppm | 24 ± 18 ppm |
| Reaction | 4-COOEt (CAS 5398-36-7) | 5-COOEt (CAS 53266-94-7) |
|---|---|---|
| Kinetic pKa of conjugate acid (amine) | 2.8 ± 0.1 | 3.2 ± 0.1 |
| Aminolysis half-life with benzylamine (1 eq, toluene reflux) | 6.8 h | 14.2 h |
| Saponification rate constant k (LiOH, THF/water, 10°C) | 0.42 L·mol⁻¹·min⁻¹ | 0.19 L·mol⁻¹·min⁻¹ |
| TBDMS protection of NH2 (conversion at 18 h) | 98% | 72% |
| Melting onset (DSC) | 169.1°C | 128.7°C |
| Photodegradation impurity at D65/24 h | 0.4% | 1.1% |